MSHL News MARSHALL EDWARDS INC
Symbol U : MSHL
Recent Sedar Documents 
Marshall Edwards CEO to Present at Needham Healthcare Conference

2012-03-28 09:00 ET - News Release

Live Webcast from New York on Wednesday, April 4

SAN DIEGO, March 28, 2012 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present an update on Marshall Edwards and the clinical development of its lead oncology drug candidates, ME-143 and ME-344, at the Needham Healthcare Conference on Wednesday, April 4, 2012 at 8:40 a.m. Eastern time from the New York Palace Hotel. A live webcast of the presentation can be accessed at www.marshalledwardsinc.com/investor . A replay will be available approximately one hour after the presentation.